Mengxuan Zuo
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 26
- Liver Disease and Transplantation 4
-
- Cancer Mechanisms and Therapy 6
-
- Cancer Immunotherapy and Biomarkers 4
-
- Renal cell carcinoma treatment 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 16
-
- Liver Disease Diagnosis and Treatment 10
-
- Immune Cell Function and Interaction 4
- Journals
- Cancer Medicine (4 papers)Therapeutic Advances in Medical Oncology (3 papers)International Journal of Surgery (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Mengxuan Zuo
31 papers receiving 305 citations
Peers
Comparison fields: 5 of 40
- Hepatology 192
- Pathology and Forensic Medicine 92
- Oncology 100
- Pulmonary and Respiratory Medicine 69
- Radiology, Nuclear Medicine and Imaging 47
Countries citing papers authored by Mengxuan Zuo
This map shows the geographic impact of Mengxuan Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxuan Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxuan Zuo more than expected).
Fields of papers citing papers by Mengxuan Zuo
This network shows the impact of papers produced by Mengxuan Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxuan Zuo. The network helps show where Mengxuan Zuo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mengxuan Zuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 24 | |
| 9 | 2023 | 13 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 68 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 26 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 7 | |
| 19 | 2019 | 3 | |
| 20 | 2019 | 0 |
About Mengxuan Zuo
Mengxuan Zuo is a scholar working on Hepatology, Pathology and Forensic Medicine and Oncology, having authored 34 papers that have together received 308 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), Liver Disease Diagnosis and Treatment (10 papers), Cancer Mechanisms and Therapy (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (4 papers), Liver Disease and Transplantation (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Hepatology (192 citations), Pathology and Forensic Medicine (92 citations) and Oncology (100 citations). Mengxuan Zuo has collaborated with scholars based in China and United States. Frequent co-authors include Peihong Wu, Chao An, Jinhua Huang, Tianqi Zhang, Yangkui Gu, Zilin Huang, Wang Li, Jibin Li, Zhijun Geng and Qifeng Chen. Their work appears in journals such as Cancer Medicine, Therapeutic Advances in Medical Oncology, International Journal of Surgery, Cancer and Journal of Personalized Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.